“NeuroQore’s Electromagnetics: A New Way to Treat Depression & Neurobehavioral Disorders” Silicon Valley medical device start-up, NeuroQore Inc., has developed a novel platform technology that it believes can be applied to many neurobehavioral disorders and could provide rapid treatment for major depressive disorder (MDD). The team is striving to put an end to the most devastating of all endings: suicide. In this interview, co-founder and CEO Mehran Talebinejad talks about his experiences in co-founding the company and what’s next for NeuroQore.
Neuro-focused prescription digital health companies are taking aim at a range of diseases from psychiatric and mental health disorders to neurodegenerative diseases. In this excerpt from our September 28 feature, “Digital Taps Into Neurological Function,” Mark Ratner talks with William Marks, MD, about Verily Life Sciences’ activities in the field.